Oral propranolol in infantile hemangiomas: Analysis of factors that affect the outcome

Conclusions: Oral propranolol at 2–3 mg/kg/day dosing has shown to be effective and safe for IHs in pediatric age group. Intervention in the early proliferative phase, with especially, the cephalic lesions result in better resolution rates with shorter duration of overall treatment.

Source: Journal of Indian Association of Pediatric Surgeons - June 5, 2019 Category: Surgery Authors: Arun Mohanan Ainipully Sarath Kumar Narayanan Arun Preeth Vazhiyodan Prathap Somnath Source Type: research